BTK inhibition sensitizes acute lymphoblastic leukemia to asparaginase by suppressing the amino acid response pathway
Miriam Butler(Cooper Medical School of Rowan University), Frank N. van Leeuwen(Princess Máxima Center), Steven M. Kornblau(The University of Texas MD Anderson Cancer Center), Britt M. T. Vervoort(Princess Máxima Center), Trisha Tee(Princess Máxima Center), Rico Hagelaar(Princess Máxima Center), Silvia Jenni(University Children's Hospital Zurich), Maria Pamela Dobay(Biogen (Switzerland)), Jules P.P. Meijerink(Erasmus MC - Sophia Children’s Hospital), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Fieke W. Hoff(University Medical Center Groningen), Roland P. Kuiper(Princess Máxima Center), Dorette S. van Ingen Schenau(Princess Máxima Center), Beat Bornhäuser(University Children's Hospital Zurich), Jiangyan Yu(Princess Máxima Center), Laurens T. van der Meer(Princess Máxima Center)
Cited by 25
Related Papers
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1
|Nature Genetics|2008|818
Surviving Stress: Modulation of ATF4-Mediated Stress Responses in Normal and Malignant Cells
|Trends in Endocrinology and Metabolism|2017|635
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|627